FindTrial
Sign In

A study to explore the bio activity of 15 years old homoeopathic preparation of Allium cepa 30c

A study to explore the bio activity of 15 years old homoeopathic preparation of Allium cepa 30c by employing double blinded randomized controlled cross-over homoeopathic pathogenetic trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/016859
Enrollment
120
Registered
2019-01-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Allium cepa 30c (15 years Old) : ROUTE of administration: Oral route DOSAGE and Frequency: Four pills of No.20 sized sucrose pills medicated by 15 years old Allium cepa 30c, four time

Sponsors

Father Muller Homoeopathic Medical College
Lead Sponsor
Father Muller Research Centre
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Individuals certified healthy as per Pre-trial/Post-trial Medical Report Proforma. Participant those who were not on any medications for two months prior to the commencement of the trial.

Exclusion criteria

Exclusion criteria: Hysterical or anxious persons (such individuals display a high incidence of Placebo effects). Persons having history of allergies, food hypersensitivity etc. Women during pregnancy, puerperium and while breast-feeding. Those who had taken birth control pills in the past 6 months. Persons having addictions-brandy,wine,alcohol,narcotics,tobacco. Persons who has undergone surgery in last two months. Participation in another clinical or proving trial during the last 6 months.

Design outcomes

Primary

MeasureTime frame
Absence or presence of pathogenesis by 15 years old preparation of Allium cepa. Comparison of quality and intensity of symptoms generated by 15 years old Allium cepa with a recently prepared one. Timepoint: The data collection will be done daily between 10 a.m and 12 noon for a maximum period of 14 days. The subjects will be observed for 30 days after the disappearance of last symptom.—

Secondary

MeasureTime frame
Blood routine, serum glucose, serum lipid, serum urea, urine routine and urine microscopy.Timepoint: Will be conducted A) During pre-trial. B) Within seven days of pathogenesis. C) Post-trial observational period (thirty days after the last disappearance of the symptom).;Variation in pulse rate variability and peripheral blood flow amongst the groups. Timepoint: Data collection will be done between 10 a.m and 12 noon during the phase of pathogenesis.—

Countries

India

Contacts

Public ContactDr Kurian P J

Father Muller Homoeopathic Medical College

drpjkurian@fathermuller.in9740935383

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026